Epigenomics, Sanger Institute Launch First Phase of Human Epigenome Project | GenomeWeb

NEW YORK, Oct. 7 (GenomeWeb News) - Epigenomics and the Wellcome Trust Sanger Institute said today that they have entered the first phase of the Human Epigenome Project (HEP) - an effort to map all the sites in the human genome where cytosine bases are modified by DNA methylation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.